Artificial Intelligence in Clinical Trials | Pharma America Articles | Dofollow Social Bookmarking Sites 2016
Facing issue in account approval? email us at info@ipt.pw

Click to Ckeck Our - FREE SEO TOOLS

1
Artificial intelligence is a field of engineering and science that focus on making intelligent machines. Artificial intelligence is a top technology that is reshaping the pharmaceutical industry's future. For ages, the pharmaceutical industry has been developing cures and treatments. Traditionally, medication design and manufacture took many years, extensive clinical studies, and sky-high prices.This has been changing with the advancement of 21st-century technology. We will see different drug designs, manufacturing, and clinical trials in the future.

Natural Language Processing (NLP), Machine learning (ML), Optical Character Recognition (OCR), and Deep Learning (DL), are examples of AI approaches. Clinical development in the traditional way is a time-consuming process with just a 10% success rate. Artificial intelligence (AI) can reduce the cost and burden of clinical development while improving the clinical phases of trials. Now many big pharmaceutical companies began to invest in AI to gear up pharmaceutical research.

Comments

Who Upvoted this Story